National Cancer Institute

FY 2016 Research Funding by Research Topic

Cancer Type Funded Amount
Agent Orange/Dioxin Related $464,469
Aging $61,038,299
Alcoholism Research $485,460
Arctic $730,070
Arthritis $505,699
Ataxia Telangiectasia $941,964
Autoimmune Diseases $6,367,408
Basic Behavioral and Social Science $62,519,302
Behavioral and Social Science $231,766,757
Biochemical Epidemiology $187,508,446
Bioengineering $151,083,918
Bone Marrow Transplantation $42,107,927
Cancer $5,206,169,249
Cancer Survivorship $180,223,502
Cervical Cancer Education $5,907,456
Chemoprevention $97,929,247
Chemotherapy $289,467,872
Childhood Cancers $206,767,589
Chronic Myeloproliferative Disorders $21,275,150
Contraception and Reproduction Research $1,333,375
Depression Research $15,055,485
Diabetes $11,617,335
Digestive Diseases $502,916,313
Down Syndrome $1,423,795
Gene Therapy $37,266,434
Gene Therapy Clinical Trials $8,653,854
Genetic Testing $31,969,055
Herpes - Genital $32,249
Herpes - Other $47,283,259
Inflammatory Bowel Disease $1,030,782
Interferon $3,696,521
Metastasis $409,622,279
Neurofibromatosis $8,057,361
Nuclear Magnetic Resonance Imaging (NMR) $82,129,673
Nursing Oncology $23,609,981
Organ Transplantation Research $52,014,489
Pesticides $1,447,286
Sleep Disorders $9,705,874
Smoking Behavior $70,024,816
Surgery $56,888,967
Taxol $16,913,742
Tuberous Sclerosis $2,075,645